XML 41 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-based Compensation Plans (Tables)
12 Months Ended
Sep. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-based Compensation Expenses Stock-based compensation expense was reported as follows in the consolidated statements of operations:

 

 

 

Fiscal Year

 

(In thousands)

 

2020

 

 

2019

 

 

2018

 

Product costs

 

$

119

 

 

$

135

 

 

$

69

 

Research and development

 

 

896

 

 

 

876

 

 

 

801

 

Selling, general and administrative

 

 

4,438

 

 

 

4,066

 

 

 

3,937

 

Total stock-based compensation expense

 

$

5,453

 

 

$

5,077

 

 

$

4,807

 

Stock Option Fair Value Assumptions and Weighted Average Fair Value of Stock Options Granted Stock option fair value assumptions and the weighted average fair value of stock options granted were as follows:

 

 

 

Fiscal Year

 

 

 

2020

 

 

2019

 

 

2018

 

Stock option fair value assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Risk-free interest rates

 

 

1.41

%

 

 

2.75

%

 

 

2.18

%

Expected life (years)

 

4.6

 

 

4.5

 

 

4.8

 

Expected volatility

 

 

39

%

 

 

34

%

 

 

33

%

Dividend yield

 

 

%

 

 

%

 

 

%

Weighted average grant date fair value of stock

    options granted

 

$

14.13

 

 

$

17.89

 

 

$

10.91

 

Schedule of Stock Option Activity

Stock option activity was as follows:

(In thousands, except per share data)

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

Options outstanding at September 30, 2017

 

 

1,002

 

 

$

21.54

 

Granted

 

 

270

 

 

 

34.08

 

Exercised

 

 

(450

)

 

 

19.46

 

Forfeited and expired

 

 

(111

)

 

 

30.18

 

Options outstanding at September 30, 2018

 

 

711

 

 

 

26.28

 

Granted

 

 

179

 

 

 

55.09

 

Exercised

 

 

(13

)

 

 

22.03

 

Forfeited and expired

 

 

(6

)

 

 

42.28

 

Options outstanding at September 30, 2019

 

 

871

 

 

 

32.18

 

Granted

 

 

299

 

 

 

41.06

 

Exercised

 

 

(125

)

 

 

22.89

 

Forfeited and expired

 

 

(105

)

 

 

41.69

 

Options outstanding at September 30, 2020

 

 

940

 

 

 

35.18

 

Options vested and exercisable at September 30, 2020

 

 

472

 

 

$

28.65

 

Schedule of Restricted Stock Activity

Restricted Stock activity was as follows:

(In thousands, except per share data)

 

Number of

Shares

 

 

Weighted

Average

Grant Price

 

Unvested restricted stock awards at September 30, 2017

 

 

68

 

 

$

23.98

 

Granted

 

 

56

 

 

 

34.38

 

Vested

 

 

(29

)

 

 

23.78

 

Forfeited

 

 

(10

)

 

 

29.10

 

Unvested restricted stock awards at September 30, 2018

 

 

85

 

 

 

30.30

 

Granted

 

 

45

 

 

 

56.05

 

Vested

 

 

(39

)

 

 

28.61

 

Forfeited

 

 

(1

)

 

 

47.86

 

Unvested restricted stock awards at September 30, 2019

 

 

90

 

 

 

43.69

 

Granted

 

 

67

 

 

 

41.40

 

Vested

 

 

(43

)

 

 

38.74

 

Forfeited

 

 

(14

)

 

 

44.76

 

Unvested restricted stock awards at September 30, 2020

 

 

100

 

 

$

44.16